Archive for June, 2003

Biotech Industry Could Turn Profitable This Decade

Biotech Industry Could Turn Profitable This Decade The U.S. biotechnology industry could turn a net profit within five to seven years if it gets a break on both regulatory and technological fronts, the author of a new report on the industry said.


Click here for reuse options!
Copyright 2003 Biotechblog

Biotech firms eye rally hungrily

Biotech firms eye rally hungrily With so many firms in dire financial straits, many executives are desperately hoping that this spring’s rally in biotech stocks will give way to a turnaround that will allow them to raise the cash they need to survive.


Click here for reuse options!
Copyright 2003 Biotechblog

Biotech Stock Report – WOW!

Biotech Stock Report – WOW! The market has gotten ahead of itself by chasing stories, but there is, in fact, fundamental improvement in the outlook for the biotech business. Wall Street is anticipating a slough of new products to hit the market in 2003/2004 and biotechs will be rewarded with earnings/profits.


Click here for reuse options!
Copyright 2003 Biotechblog

Schering-Plough: Drugmaker, Heal Thyself

Schering-Plough: Drugmaker, Heal Thyself It has a potential blockbuster and a savvy new CEO. With federal probers and Claritin’s expired patent to deal with, it will need both


Click here for reuse options!
Copyright 2003 Biotechblog

Geron's the Biotech of the Day

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]


Click here for reuse options!
Copyright 2003 Biotechblog

Geron’s the Biotech of the Day

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]


Click here for reuse options!
Copyright 2003 Biotechblog

India 'to approve GM potato'

India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets of many of the poorest is expected to be approved in India within six months.


Click here for reuse options!
Copyright 2003 Biotechblog

India ‘to approve GM potato’

India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets of many of the poorest is expected to be approved in India within six months.


Click here for reuse options!
Copyright 2003 Biotechblog

Genentech's Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]


Click here for reuse options!
Copyright 2003 Biotechblog

Genentech’s Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]


Click here for reuse options!
Copyright 2003 Biotechblog

%d bloggers like this: